Identifying and Overcoming Challenges in Developing Effective Treatments for Usher 1B: A Workshop Report

Area of Science:

• Ophthalmology and genetics research.
• Retinal degenerative diseases.

Background:

• Usher syndrome type 1B (USH1B) is a genetic disorder causing vision and hearing loss.
• Current research faces hurdles in disease modeling and clinical trial development.

Purpose of the Study:

• To identify challenges and opportunities for developing treatments for Usher syndrome type 1B.
• To foster collaboration among researchers, clinicians, patients, and regulators.

Main Methods:

• A virtual workshop convened experts, including researchers, clinicians, industry representatives, and patient advocates.
• Discussions covered myosin VIIA protein function, disease models, natural history data, and emerging therapies.

Main Results:

• Key challenges include limitations of current mouse models and the need for better human retinal analogues (organoids, large animals).
• Discussions highlighted the necessity for improved clinical trial designs with appropriate outcome measures and multimodal imaging.
• Emerging treatments include genetic augmentation and gene-agnostic approaches for USH1B.

Conclusions:

• Collaborative initiatives like the workshop are vital for advancing Usher syndrome type 1B treatment development.
• Overcoming challenges in modeling and trial design is essential for the successful implementation of effective USH1B therapies.